MRNAModerna
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 73). Price is +224% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 15, 2026, a few days of normal trading to cover. Down 16% since the previous count, down from 14.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MRNA is trading
Moderna is +93% over the past year while the S&P 500 is +18%: 74 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +224%
vs 200-day average · a clear uptrend
- RSI (14)
- 73
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-10-09
- $62.96
- 1 monthS&P 500 +2.7%
- −7.7%
- 1 yearS&P 500 +18%
- +93%
- 5 yearsS&P 500 +88%
- −81%
- vs 50-day average$136.33
- +65%
- 52-week high
- $225.03
- 52-week low
- $22.36
- Annualised volatility
- 150%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$434K
| Year | Return |
|---|---|
| 2026 (year to date) | +663% |
| 2025 | −29% |
| 2024 | −58% |
| 2023 | −45% |
| 2022 | −29% |
| 2021 | +143% |
| 2020 | +434% |
| 2019 | +28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 5 of 8 | +11% |
| Feb | 8 | 3 of 8 | +1.6% |
| Mar | 8 | 4 of 8 | +1.9% |
| Apr | 8 | 5 of 8 | +9.7% |
| May | 8 | 5 of 8 | +5.8% |
| Jun | 8 | 4 of 8 | +1.3% |
| Jul | 8 | 5 of 8 | +8.4% |
| Aug | 8 | 3 of 8 | +11% |
| Sep | 8 | 5 of 8 | +3.0% |
| Oct | 8 | 4 of 8 | −0.65% |
| Nov | 7 | 5 of 7 | +21% |
| Dec | 7 | 3 of 7 | −3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry